DIA Co-located Conference to Examine Outsourcing and Project Management Best Practices

Share Article

The Drug Information Association (DIA) will host two co-located conferences from October 23-24 in Washington DC.

The Drug Information Association (DIA) will host two co-located conferences from October 23-24 in Washington DC.

The 3rd Annual Outsourcing Summit will convene sponsor companies and service providers for a discussion on how to apply outsourcing best practices to one's own projects and corporate culture. Featured topics will include:

  •     Proposals, RFPs and Budgets
  •     Expediting the Startup Phase
  •     The Outsourcing Strategy Revolving Door and its Impact on Performance
  •     How to address Persistent Problems
  •     Unraveling the mysteries in India, China, and South America outsourcing
  •     Sponsor/Provider/Investigator Triad

Learn pharma, biotech, and medical devices project management best practices during Project Management Excellence in Life Sciences: Balancing Art and Science. This conference will explore the skills, processes, and tools necessary to achieve project management success at one's organization. Topics will include:

  •     Strategic planning versus operational excellence
  •     Metrics and regulatory impact
  •     Strategies for getting a seat at the executive table
  •     Tools to efficiently manage projects and programs
  •     Redefining project management in a matrix environment
  •     Functional PMs versus global PMs
  •     Metrics-driven performance
  •     Change management

In addition, two pre-Conference tutorials will take place on October 22:

  •     Project Management in Life sciences: How Well is it Really Done? Research Outputs from a Global Study

•    
Implementing Critical Chain In The Pharmaceutical And Medical Device Industry

About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, and Mumbai, India, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit http://www.diahome.org or call 215-442-6100.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Joe Krasowski
Visit website